Interní Med. 2010; 12(9): 407-410

The irritable colon and functional constipation

MUDr.Karel Hrubant
1. lékařská fakulta, IV. interní klinika, Univerzita Karlova v Praze;

The irritable colon and functional constipation are the most frequent functional disorders of the digestive system and occur in a high

percentage of the population in developed countries. The predominant symptom of the irritable colon is abdominal pain and/or abdominal

discomfort, which is eased by defecation or a change in the form or frequency of the stools, and malfunction in evacuation. The

main symptom of functional constipation is a permanent difficulty in defecation associated with the infrequent passage of hard stools,

often associated with the feeling of incomplete emptying. The pathogenesis of both conditions is not known despite extensive research.

We suppose this is a defect of the neurohumoral regulatory function of the colon, originating in people with a genetic predisposition

and an incidence of adverse external factors. This dysfunctional regulation leads to a change of colonic motility, colonic secretion and

visceral sensitivity of the bowel, the consequence of which is the occurrence of characteristic symptoms. Both conditions run a chronic

course, often markedly reducing the quality of a patient’s life. The diagnosis can be established on the basis of current characteristic

symptoms, negative physical findings and in the absence of alarming symptoms as a positive diagnosis. Other investigations, except

the differentiation of specific types of severe functional constipation, are not necessary. Therapy is complex, targeting the predominant

symptoms, the basis for success being the creation of mutual trust between doctor and patient.

Keywords: irritable colon, functional constipation, diarrhoea, abdominal pain, abdominal discomfort

Published: October 1, 2010  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Hrubant K. The irritable colon and functional constipation. Interní Med. 2010;12(9):407-410.
Download citation

References

  1. Lukáš K, Hep A. Římská klasifikace III (2006). Čes a Slov Gastroent a Hepatol 2007; 61(1): 39-45.
  2. Francis CY, Whorwell PJ. The irritable bowel syndrome. Postgrad Med J 1997; 73(855): 1-7. Go to original source... Go to PubMed...
  3. Dalton CB, Drossman DA. Diagnosis and treatment of irritable bowel syndrome. Am Fam Physician 1997; 55(3): 875-880. Go to PubMed...
  4. Brandt LJ, Bjorkman D, Fennerty MB, et al. Systematic review on the management of irritable bowel syndrome in North America. Am J Gastroenterol 2002; 97(11 Suppl.): S7-S26. Go to original source... Go to PubMed...
  5. Foxx-Orenstein AE, McNally MA, Odunsi ST. Update on constipation: one treatment does not fit all. Cleve Clin J Med 2008; 75(11): 813-824. Go to original source... Go to PubMed...
  6. Mařatka Z. Funkční trávicí poruchy. In Mařatka Z. Gastroenterologie. Praha, Karolinum, 1999: 407-433.
  7. Manning AP, Thompson WG, Newton KW, Morris AF. Towards positive diagnosis of the irritable bowel. Br Med J 1978; 2(6138): 653-654. Go to original source... Go to PubMed...
  8. Drossman DA. The functional gastrointestinal disorders and the Rome III process. Gastroenterology 2006; 130(5): 1377-1390. Go to original source... Go to PubMed...
  9. Mařatka Z. Zácpa. In Mařatka Z. Klinická gastroenterologie. 1. vyd. Praha, Avicenum, 1988: 341-352.
  10. Foxx-Orenstein AE. IBS - review and what´s new. Med Gen Med 2006; 8(3): 20.
  11. Crowell MD. The role of serotonin in the pathophysiology of irrittable bowel syndrome. Am J Manag Care 2001; 7(8 Suppl.): S252-S206. Go to PubMed...
  12. Gershon MD. Nerves, reflexes, and the enteric nervous system: pathogenesis of the irritable bowel syndrome. J Clin Gastroenterol 2005; 39(5 Suppl. 3): S184-S193. Go to original source... Go to PubMed...
  13. Coates MD, Mahoney CR, Linden DR. Molecular defects in mucosal serotonin kontent and decreased serotonin reuptake transporter in ulcerative colitis and irritable bowel syndrome. Gastroenterology 2004; 126(7): 1657-1664. Go to original source... Go to PubMed...
  14. Miwa J, Echizen H, Matsueda K. Umeda N. Patiens with constipation-predominant irritable bowel syndrome (IBS) may have elevated serotonin concentrations in colonic mucosa as compared with diarrhoea-predominant patiens and subjects with normal bowel habits. Digestion 2001; 63(3): 188-194. Go to original source... Go to PubMed...
  15. Morgan V, Puckens D, Gautam S, et al. Amitriptyline reduces rectal pain related activation of the anterior cingulate cortex in patients with irritable bowel syndrome. Gut 2005; 54(5): 569-573. Go to original source... Go to PubMed...
  16. Dunlop SP, Coleman NS, Blackshaw E, et al. Abnormalities of 5-hydroxytryptamine metabolism in irritable bowel syndrome. Clin Gastroenterol Hepatol 2005; 3(4): 349-357. Go to original source... Go to PubMed...
  17. Lukáš K. Funkční střevní dyspepsie v terénní praxi. Interní Med 2007; 9(10): 420-424.
  18. Seifert B. Aktuální pohled praktického lékaře na dyspeptický syndrom. Folia Gastroenterol Hepatol 2007; 5(2): 9-15.
  19. Longstreth GF. Irritable bowel syndrome. Diagnosis in the managed care era. Dig Dis Sci 1997; 42(6): 1105-1111. Go to original source... Go to PubMed...
  20. Cash BD, Schoenfeld P, Chey WD. The utility of diagnostic tests in irritable bowel syndrome patiens: a systematic review. Am Gastroenterol 2002; 97(11): 2812-2819. Go to original source... Go to PubMed...
  21. Adeniji OA, Bamett CB, Palma JA. Durability of the diagnosis of irritable bowel syndrome based on clinical criteria. Dig Dis Sci 2004; 49(4): 572-574. Go to original source... Go to PubMed...
  22. Lukáš K, Hep A. Zácpa. Čes Ger Rev 2005; 3(3): 19-20.
  23. Ford AC, Halley NJ, Spiegel BM, et al. Effect of fibre, antispasmodics, and peppermint oil in the treatment of irritable bowel syndrome: systematic review and meta-analysis. BMJ 2008; 337: a2313. Go to original source... Go to PubMed...
  24. Brandt LJ, Chey WD, Foxx-Orenstein AE, et al. An Evidence-Based Position Statement on the Management of Irritable Bowel Syndrome. Am J Gastroenterol 2009; 104(Suppl. 1): S1-S35. Go to original source... Go to PubMed...
  25. Lukáš M. Postavení probiotika v terapii gastrointestinálních onemocnění u seniorů. Čes Ger Rev 2008; 6(2): 116-119.
  26. Wald A. Constipation. Med Clin North Am 2000; 84(5): 1231-1246. Go to original source... Go to PubMed...




Internal Medicine for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.